NMT1 and trypanosomiasis: The enzyme myristoyl-CoA:protein N-myristoyltransferase (NMT) has recently been validated as a promising drug target in trypanosomiasis (Frearson et al., 2010) and malaria (Wright et al., 2014), diseases caused by the protozoan parasites Trypanosoma brucei and species of Plasmodium, respectively.